Kisspeptin in the Evaluation of Delayed Puberty
ClinicalTrials.gov · NCT01438034 · Registry updated: 2023-10-19
- Condition / research focus
- Delayed Puberty; Kallmann Syndrome; Hypogonadotropic Hypogonadism; GnRH Deficiency
- Sponsor
- Massachusetts General Hospital
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2013-06-08. Completion: 2021-09-10 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- kisspeptin 112-121 (drug) — also listed as: metastin 45-54
- GnRH (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Massachusetts General Hospital
Boston, Massachusetts, United States